Top 10 Clinical Trends for August 2015

#6 Clinical Trend: Entresto

Entresto, the new heart failure drug from Novartis, has been approved by the US Food and Drug Administration for patients with worsening heart failure. Some physicians are strongly advocating for early adoption of the drug. This term likely increased as a result of physicians trying to educate themselves on what they will recommend to their patients regarding this new pharmaceutical option.

For more in-depth clinical information, see Heart Failure.

Medscape © 2015  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Ryan Syrek. Top 10 Clinical Trends for August 2015 - Medscape - Aug 21, 2015.